02.12.2016 Views

Journal Thoracic Oncology

WCLC2016-Abstract-Book_vF-WEB_revNov17-1

WCLC2016-Abstract-Book_vF-WEB_revNov17-1

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Abstracts <strong>Journal</strong> of <strong>Thoracic</strong> <strong>Oncology</strong> • Volume 12 Issue S1 January 2017<br />

POSTER SESSION 1 - P1.08: SURGERY<br />

MINIMAL INVASIVE SURGERY –<br />

MONDAY, DECEMBER 5, 2016<br />

P1.08-039 SYSTEMATIC REVIEW AND UPDATED META-ANALYSIS<br />

OF UNIPORTAL VERSUS MULTIPORTAL VIDEO-ASSISTED<br />

THORACOSCOPIC SURGERY FOR LUNG CANCER<br />

Mariusz Kowalewski 1 , Maciej Dancewicz 2 , Mariusz Bella 2 , Tomasz Szczęsny 2 ,<br />

Przemysław Bławat 2 , Marzena Lewandowska 2 , Aleksandra Chrzastek 3 , Janusz<br />

Kowalewski 3<br />

1 Department of Hygiene, Epidemiology and Ergonomics, Division of Ergonomics<br />

and Physical Effort, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus<br />

University in Torun, Bydgoszcz/Poland, 2 Department of <strong>Thoracic</strong> Surgery and<br />

Tumors, Franciszek Lukaszczyk Memorial Oncological Center in Bydgoszcz,<br />

Bydgoszcz/Poland, 3 Department of <strong>Thoracic</strong> Surgery and Tumors, Collegium<br />

Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz/Poland<br />

Background: Uniportal video-assisted thoracoscopic surgery (VATS) is a<br />

challenging surgical procedure that poses substantial technical difficulties<br />

compared to multiportal VATS but has been associated with favorable<br />

outcomes in studies reported to date. Methods: On-line databases were<br />

screened until June 2016. Meta-analysis aimed to compare clinical outcomes of<br />

uniportal and multiportal VATS lobectomy for patients with lung cancer.<br />

Endpoints assessed included perioperative mortality, operative time and<br />

blood loss; length of hospital stay; duration of postoperative drainage; rates<br />

of conversion to open thoracotomy; number of harvested lymph nodes and<br />

overall morbidity. Risk Ratios (RR)/Mean Difference (MD) and corresponding<br />

95% Confidence Intervals (95%CIs) served as primary statistics. Results:<br />

Twelve studies were included (among them 1 randomized trial) that enrolled<br />

N=2,476 patients. There was no difference in the 30-day mortality: (N=2,476);<br />

RR (95%CIs) 0.32 (0.03-3.01); p=0.32; Event rates: 0.10% (1/1,021) vs 0.07%<br />

(1/1,455); no difference were demonstrated for conversion-to-thoracotomy:<br />

0.91 (0.48-1.73); p=0.77; similarly there were no differences in regard to<br />

operative times: MD (95%CIs): 3.50 ([-12.35]-19.34) min; p=0.67 and blood loss:<br />

-2.15 ([-17.13]-12.83) ml; p=0.78. There was no statistically significant difference<br />

between number of harvested lymph nodes: 18.4±6.6 vs 19.4±8.5; MD<br />

(95%CIs): -0.34 ([-1.39]-0.70) node; p=0.52. Uniportal VATS was associated<br />

with significantly shorter duration of chest tube drainage: -0.61 ([-0.99]-[-<br />

0.23]) days; p=0.002 (Figure 1A); and length of hospital stay: -0.58 ([-0.77]-[-<br />

0.40]) days; p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!